Reducing NOVA1 helps prevent tumour growth in lung cancer
Researchers have identified a gene that when inhibited, reduced human non-small cell lung cancer tumours from growing...
List view / Grid view
Researchers have identified a gene that when inhibited, reduced human non-small cell lung cancer tumours from growing...
Scientists in the U.S. have found that human lung cancer cells resist dying by controlling parts of the ageing process. The discovery could help us better understand ageing and eventually lead to new treatments for cancer.
High levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer.
Scientists in Japan have discovered a promising new biomarker – cytoskeleton-associated protein 4 (CKAP4) – for lung cancer, potentially transforming the way the disease is diagnosed and treated.
Doctors may soon be able to predict the efficacy of a widely used lung cancer drug based on an imaging agent and a simple scan.
Scientists have used molecular simulations to understand the resistance to osimertinib - an anticancer drug used to treat types of lung cancer...
Researchers in Switzerland have identified biomarkers in the blood that can predict which patients are likely to respond favourably to immunotherapy treatment for cancer.
Scientists at Massachusetts General Hospital (MGH) have identified how a type of lung cancer co-opts a portion of the immune system via bone marrow to increase tumour progression.
NatD, which mediates N-alpha-terminal acetylation of histone H4, found to promote lung cancer progression...
Researchers have identified a rare fusion involving the gene MET leading researchers to treat the cancer with a targeted therapy...
Researchers have developed a radioactive ‘tracer’ molecule to detect myeloid-derived suppressor cells’ accumulating in the lung in preparation for the arrival of breast cancer cells...
An experimental immuno-oncology treatment will move into early phase clinical trials for patients with advanced solid tumours...
Data mining of medical images with radiomics offers clinicians a way to characterise lung tumours and improve precision medicine...
A new study conducted by an international team of lung cancer researchers have identified new genetic variants for lung cancer risk.
Lung cancer screening is likely to be cost-effective, particularly if it also identifies other tobacco-related conditions in high-risk people, suggests new research.